ABCL 10-Q: SEC filing

AbCellera Biologics

Filed with the SEC on Nov 9, 2026 · accession 0001703057-26-000059

ABCL filed a 10-Q (quarterly report) with the SEC on Nov 9, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved +5.2% by the first close after the filing.

Summary of the filing

AbCellera Biologics filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results including revenue, expenses, and a recent underwritten public offering.

For details, click here →How to read a 10-Q →

Key details

FilerAbCellera Biologics Inc.

How ABCL stock reacted

Close before

$11.88

Nov 6, 2026

First close after

+5.22%

$12.50

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for ABCL, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ABCL?

Click here

Frequently asked questions

What did ABCL file with the SEC on Nov 9, 2026?

ABCL filed a 10-Q (SEC filing). AbCellera Biologics filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results including revenue, expenses, and a recent underwritten public offering.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did ABCL stock react to this filing?

ABCL closed at $11.88 before the filing and $12.50 on Nov 9, 2026 (+5.22%).

Other ABCL SEC filings

Get alerts when ABCL files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

ABCL overview ABCL analysis ABCL news Latest SEC filings